From: Tumor mutational burden is associated with poor outcomes in diffuse glioma
 | Number of mutant group | Number of wildtype group | Median TMB of mutant group | Median TMB of wildtype group | P value (Mann-Whitney test) | False discovery rate (FDR) | Adjust p-value (bonferroni) |
---|---|---|---|---|---|---|---|
IDH1 | 413 | 484 | 0.53 | 0.97 | 2.3E-58 | 4.6E-57 | 4.6E-57 |
TP53 | 317 | 580 | 0.67 | 0.81 | 5.5E-02 | 5.5E-02 | 1.0E+ 00 |
ATRX | 203 | 694 | 0.61 | 0.81 | 1.2E-05 | 1.6E-05 | 2.4E-04 |
TTN | 149 | 748 | 1.11 | 0.69 | 3.9E-20 | 3.9E-19 | 7.9E-19 |
PTEN | 136 | 761 | 1.045 | 0.67 | 1.7E-18 | 1.2E-17 | 3.5E-17 |
CIC | 106 | 791 | 0.47 | 0.78 | 1.4E-11 | 3.4E-11 | 2.7E-10 |
EGFR | 89 | 808 | 1.08 | 0.69 | 2.1E-14 | 1.1E-13 | 4.3E-13 |
MUC16 | 74 | 823 | 1.06 | 0.72 | 5.6E-10 | 1.0E-09 | 1.1E-08 |
PIK3CA | 74 | 823 | 0.92 | 0.72 | 1.4E-03 | 1.8E-03 | 2.9E-02 |
NF1 | 70 | 827 | 0.9 | 0.72 | 1.2E-02 | 1.4E-02 | 2.4E-01 |
PIK3R1 | 60 | 837 | 0.89 | 0.72 | 2.7E-02 | 2.9E-02 | 5.5E-01 |
RYR2 | 58 | 839 | 0.985 | 0.72 | 2.7E-02 | 2.9E-02 | 5.5E-01 |
FLG | 57 | 840 | 1.33 | 0.72 | 1.8E-13 | 5.9E-13 | 3.6E-12 |
FUBP1 | 46 | 851 | 0.5 | 0.75 | 1.8E-13 | 5.9E-13 | 3.6E-12 |
SYNE1 | 45 | 852 | 4 | 0.72 | 6.8E-11 | 1.5E-10 | 1.4E-09 |
HMCN1 | 43 | 854 | 1.08 | 0.72 | 2.0E-08 | 3.0E-08 | 3.9E-07 |
PKHD1 | 42 | 855 | 1.14 | 0.72 | 2.6E-07 | 3.7E-07 | 5.2E-06 |
LRP2 | 41 | 856 | 1.25 | 0.72 | 1.2E-10 | 2.4E-10 | 2.4E-09 |
RB1 | 41 | 856 | 1.22 | 0.72 | 9.9E-09 | 1.7E-08 | 2.0E-07 |
SPTA1 | 41 | 856 | 1.25 | 0.72 | 3.0E-12 | 8.7E-12 | 6.1E-11 |